MARTA
ALONSO PEÑA
Investigadora en el periodo 2015-2019
Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (8)
2024
-
Clinical and genetic factors involved in Porto-sinusoidal vascular disorder after oxaliplatin exposure
Digestive and Liver Disease
2023
-
Innovative Therapeutic Approaches in Non-Alcoholic Fatty Liver Disease: When Knowing Your Patient Is Key
International Journal of Molecular Sciences, Vol. 24, Núm. 13
2022
-
Beneficial effect of ursodeoxycholic acid in patients with acyl-CoA oxidase 2 (ACOX2) deficiency–associated hypertransaminasemia
Hepatology, Vol. 76, Núm. 5, pp. 1259-1274
-
Impact of Liver Inflammation on Bile Acid Side Chain Shortening and Amidation
Cells, Vol. 11, Núm. 24
-
Pathophysiological mechanisms in non-alcoholic fatty liver disease: From drivers to targets
Biomedicines, Vol. 10, Núm. 1
2019
-
Causes of hOCT1-Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor-Selective Gene Therapy
Hepatology, Vol. 70, Núm. 4, pp. 1246-1261
-
Pharmacogenetics of hepatocellular carcinoma and cholangiocarcinoma
Cancer Drug Resistance, Vol. 2, Núm. 3, pp. 680-709
-
Role of transportome in the pharmacogenomics of hepatocellular carcinoma and hepatobiliary cancer
Pharmacogenomics, Vol. 20, Núm. 13, pp. 957-970